臨床泌尿器科68巻4号

2014年04月発行

増刊号特集 前立腺癌の診療ナビゲーション―わかりやすく丁寧に！

Ⅰ　前立腺癌とは

2．前立腺癌の疫学

著者： 中井康友¹ 野々村祝夫¹

所属機関： ¹大阪大学大学院医学系研究科器官制御外科学（泌尿器科）

ページ範囲：P.21 - P.26

文献概要

002


Q　前立腺癌の罹患率，生存率，死亡率，危険因子について教えてください。また，偶発癌，オカルト癌，ラテント癌についても言及してください。


Point

●現在，前立腺癌の年齢調整罹患率は第4位，年齢調整死亡率は第7位。

●年齢調整罹患率は上昇が見込まれるが，年齢調整死亡率は漸減傾向。

●5年生存率は年々向上しており，限局癌は100％，領域癌は94.8％，遠隔癌は45.2％。

参考文献

1）Matsuda A, Marugame T, Kamo KI, et al：The Japan Cancer Surveillance Research Group：Cancer incidence and incidence rates in Japan in 2005：based on data from 12 population-based cancer registries in the Monitoring of Cancer Incidence in Japan（MCIJ）Project. Jpn J Clin Oncol 41：139-147, 2011

2）厚生労働省大臣官房統計情報部：人口動態統計

3）国立がん研究センターがん対策情報センター：がん・統計白書2012―データに基づくがん対策のために．篠原出版新社，東京，2012

4）中田誠司，大竹伸明，久保田裕，他：群馬県における前立腺癌の罹患率，臨床病期，組織学的分化度の推移．泌尿紀要50：165-170，2004

5）Okihara K, Nakanishi H, Nakamura T, et al：Clinical characteristics of prostate cancer in Japanese men in the eras before and after serum prostate-specific antigen testing. Int J Urol 12：662-667, 2005

6）国立がん研究センターがん対策情報センター：全国がん罹患モニタリング集計―2003-2005年生存率報告．2013

7）独立行政法人国立がん研究センターがん研究開発費「地域がん登録制度向上と活用に関する研究」平成22年度報告書

8）Howlader N, Noone AM, Krapcho M, et al（eds）：SEER Cancer Statistics Review, 1975-2010, National Cancer Institute. http://seer.cancer.gov/csr/1975_2010/, based on November 2012 SEER data submission, posted to the SEER web site, 2013

9）Steinberg GD, Carter BS, Beaty TH, et al：Family history and the risk of prostate cancer. Prostate 17：337-347, 1990

10）Gronberg H, Damber L and Damber JE：Familial prostate cancer in Sweden：a nationwide register cohort study. Cancer 77：138-143, 1996

11）Cook LS, Goldoft M, Schwartz SM, et al：Incidence of adenocarcinoma of the prostate in Asian immigrants to the United States and their descendants. J Urol 161：152-155, 1999

12）Van Die MD, Bone KM, Williams SG, et al：Soy and soy isoflavones in prostate cancer：a systematic review and meta-analysis of randomized controlled trials. BJU Int, 2013（in press）

13）Gerber M：Omega-3 fatty acids and cancers：a systematic update review of epidemiological studies. Br J Nutr 107 Suppl 2：S228-S239, 2012

14）Norrish AE, Ferguson LR, Knize MG, et al：Heterocyclic amine content of cooked meat and risk of prostate cancer. J Natl Cancer Inst 91：2038-2044, 1999

15）Michaud DS, Augustsson K, Rimm EB, et al：A prospective study on intake of animal products and risk of prostate cancer. Cancer Causes Control 12：557-567, 2001

16）Cross AJ, Peters U, Kirsh VA, et al：A prospective study of meat and meat mutagens and prostate cancer risk. Cancer Res 65：11779-11784, 2005

17）Rodriguez C, McCullough ML, Mondul AM, et al：Meat consumption among black and white men and risk of prostate cancer in the Cancer Prevention Study Ⅱ Nutrition Cohort. Cancer Epiemiol Biomarkers Prev 15：211-216, 2006

18）Koutros S, Cross AJ, Sandler DP, et al：Meat and meat mutagens and risk of prostate cancer in the Agricultural Health Study. Cancer Epidemiol Biomarkers Prev 17：80-87, 2008

19）Shinha R, Park Y, Graubard BI, et al：Meat and meat-related compounds and risk of prostate cancer in a large prospective cohort study in the United States. Am J Epidemiol 170：1165-1177, 2009

20）Richman EL, Kenfield SA, Stampfer MJ, et al：Egg, red meat and poultry intake and risk of lethal prostate cancer in the prostate-specific antigen-era：incidence and survival. Cancer Prev Res（Phila）12：2110-2121, 2011

21）John EM, Stern MC, Shinha R, et al：Meat consumption, cooking practices, meat mutagens, and risk of prostate cancer. Nutr Cancer 63：525-537, 2011

22）Wright JL, Neuhouser ML, Lin DW, et al：AMACR polymorphisms, dietary intake of red meat and dairy and prostate cancer risk. Prostate 71：498-506, 2011

23）Major JM, Cross AJ, Watters JL, et al：Patterns of meat intake and risk of prostate cancer among African-Americans in a large prospective study. Cancer Causes Control 22：1691-1698, 2011

24）Punnen S, Hardin J, Cheng I, et al：Impact of meat consumption, preparation, and mutagens on aggressive prostate cancer. PLoS One 6：e27711, 2011

25）Masko EL, Allott EH and Freedland SJ：The relationship between nutrition and prostate cancer：is more always better? Eur Urol 63：810-820, 2013

26）Nakai Y and Nonomura N：Inflammation and prostate carcinogenesis. Int J Urol 20：150-160, 2013

27）日本泌尿器科学会，日本病理学会，日本医学放射線学会（編）：前立腺癌取扱い規約，第4版．金原出版，東京，2010

28）Zigeuner RE, Lipsky K, Riedler I, et al：Did the rate of incidental prostate cancer change in the era of PSA testing? A retrospective study of 1127 patients. Urology 62：451-455, 2003

29）Merrill RM and Wiggins CL：Incidental detection of population-based prostate cancer incidence rates through transurethral resection of the prostate. Urol Oncol 7：213-219, 2002

30）Jones JS, Folis HW and Johnson JR：Probability of finding T1a and T1b（incidental）prostate cancer during TURP has decreased in the PSA era. Prostate Cancer Prostatic Dis 12：57-60, 2009

31）菅野ひとみ，梅本　晋，泉　浩司，他：TURP後の前立腺残存組織における癌の発育―前立腺全摘除術標本の病理組織学的検討．日泌尿会誌97：649-659，2006

32）中西真一，後藤崇之，澤田篤郎，他：経尿道的前立腺切除術によって発見された前立腺偶発癌（A癌）の臨床的検討．泌尿紀要55：5-8，2009

33）Andrèn O, Garmo H, Mucci L, et al：Incidence and mortality of incidental prostate cancer：a Swedish register-based study. Br J Cancer 100：170-173, 2009

34）Capitanio U, Scattoni V, Freschi M, et al：Radical prostatectomy for incidental（stage T1a-T1b）prostate cancer：analysis of predictors for residual disease and biochemical recurrence. Eur Urol 54：118-125, 2008

35）Nakagawa T, Kanai Y, Komiyama M, et al：Characteristics of prostate cancers found in specimens removed by radical cystoprostatectomy for bladder cancer and their relationship with serum prostate-specific antigen level. Cancer Sci 100：1880-1884, 2009

36）Damiano R, Di Lorenzo G, Cantiello F, et al：Clinicopathologic features of prostate adenocarcinoma incidentally discovered at the time of radical cystectomy：an evidence-based analysis. Eur Urol 52：648-657, 2007

37）Fujikawa S, Matsuura H, Kanai M, et al：Natural history of human prostate gland：morphometric and histopathological analysis of Japanese men. Prostate 65：355-364, 2005

38）Yatani R, Chigusa I, Akazaki K, et al：Geographic pathology of latent prostatic carcinoma. Int J Cancer 29：611-616, 1982

39）Breslow N, Chan CW, Dhom G, et al：Latent carcinoma of prostate at autopsy in seven areas. Int J Cancer 20：680-688, 1977

40）Yatani R, Shiraishi T, Nakakuki K, et al：Trends in frequency of latent prostatic carcinoma in Japan from 1965-1979 to 1982 to 1986. J Natl Cancer Inst 80：683-687, 1988

41）Konety BR, Bird VY, Deorah S, et al：Comparison of the incidence of latent prostate cancer detected at autopsy before and after the prostate specific antigen era. J Urol 174：1785-1788, 2005

42）新井冨生：高齢者のoccult cancer（原発不明癌）．日老医誌48：297-304，2011